At AI Medical Solutions, we seek to drive smart care in the field of visual health in a collaborative way. Our advanced technology enables us to detect and treat early eye conditions that, if not addressed in time, can lead to avoidable blindness.
Ai
Medical
Solutions
WHAT DO WE DO?
In our days, visual impairments affect more than 2.2 billion people worldwide, with older adults being the most vulnerable group to conditions such as macular degeneration, glaucoma, and cataracts. It is estimated that 1 billion of these cases could have been prevented with timely access to medical care. However, the shortage of specialists remains a major challenge, delaying the detection and diagnosis of eye diseases.
millions of
people
At least 1,000
suffer from a visual impairment that could have been avoided or has not yet been treated.
The 90%
of the loss
Of vision
It can be prevented with early detection and treatment.
GLOBAL
DATA
At the current rate, vision loss will increase to
1,700
millions of
people in 2050
It is estimated that current eye health systems will not be able to cope with future needs.
"AL PROVIDES A COST-EFFECTIVE SOLUTION TO ADDRESS THE SHORTAGE OF SPECIALISTS AND EXPAND THE SERVICES OF OPHTHALMOLOGICAL CARE"
ACCESS
CHANNEL
OUR
PARTNERS
"OUR VALUABLE COLLABORATORS ARE FUNDAMENTAL TO OUR SUCCESS. TOGETHER WE WORK TO CONTRIBUTE TO THE TRANSFORMATION OF HEALTHCARE BY BRINGING INNOVATIVE SOLUTIONS TO OUR PATIENTS AND HEALTH PROFESSIONALS."
Altris AI is an Artificial Intelligence web platform for interpreting macular OCT. It detects over 70 pathologies and biomarkers, including dry and wet age-related macular degeneration, diabetic retinopathy, and early-stage glaucoma.
• Improves patient triage
• Detects over 70 retinal biomarkers and pathologies
• More detailed screening enables the detection of more early cases and the application of more effective treatments
• Early assessment of glaucoma risk (a unique AI application in ophthalmology and optometry)
• Quantitative biomarker analysis: for monitoring how pathologies change over time
IT IS AN ARTIFICIAL INTELLIGENCE SOLUTION DEVELOPED FOR THE DETECTION OF THE MAIN EYE PATHOLOGIES:
The promise of OphtAI is to provide preventive care, since it allows early detection of the main retinal pathologies in a few seconds, facilitating a timely referral to specialized services, thus avoiding the development of the aforementioned pathologies.
-
Diabetic retinopathy
-
Diabetic Macular Edema
-
Glaucoma
-
Macular Degeneration
-
Age-related (AMD)
-
Drusen
VIRTUAL AGENT OF AI ROBOTICS
The first platform for Complete Automatic Diagnosis: SmartVision™ Ophthalmic Diagnosis Report with comprehensive prescriptions and surgical planning in just 6 minutes.
MIKAJAKI (Geneva) has revolutionized ophthalmic diagnosis with artificial intelligence, robotics, and virtual agents through the Ariane Ophthalmic Suite. Its innovative EyeLib™ station, fully autonomous and compact (less than 2 m²), performs exams in under 6 minutes using 10 integrated technologies, including anterior and posterior OCT, ocular biometry, wavefront refraction, and tonometry. EyeLib™ enables efficient and accurate diagnoses, whether in-person or via telemedicine, expanding access to eye care.
Contact us
If you are interested in learning more about our AI, scheduling a meeting or receiving additional information about our technologies, we invite you to contact us via our email.